4-AcO-DPT
Names
Preferred IUPAC name
3-[2-(Diethylamino)ethyl]-1H-indol-4-yl acetate
Other names
Depracetin
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C18H26N2O2/c1-4-10-20(11-5-2)12-9-15-13-19-16-7-6-8-17(18(15)16)22-14(3)21/h6-8,13,19H,4-5,9-12H2,1-3H3
    Key: KRUGABVNKKKCJN-UHFFFAOYSA-N
  • CCCN(CCC)CCC1=CNC2=C1C(=CC=C2)OC(=O)C
Properties
C18H26N2O2
Molar mass 302.418 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
This article provides insufficient context for those unfamiliar with the subject. Please help improve the article by providing more context for the reader. (March 2021) (Learn how and when to remove this template message)

4-Acetyloxy-N,N-dipropyltryptamine (or 4-AcO-DPT) is a tryptamine derivative. 4-AcO-DPT has been sold as a designer drug.[1] It is an ester of 4-HO-DPT, a psychedelic tryptamine first synthesized by Alexander Shulgin. Anecdotal reports indicate that 4-AcO-DPT exerts psychoactive effects in humans, however, the pharmacology of 4-AcO-DPT has not been examined.[2][3]

See also

References

  1. ^ Schifano, Fabrizio; Orsolini, Laura; Papanti, Duccio; Corkery, John (2017). Neuropharmacology of new psychoactive substances (NPS) : the science behind the headlines. Current Topics in Behavioral Neurosciences. Vol. 32. Cham, Switzerland: Springer. pp. 351–380. doi:10.1007/978-3-319-52444-3. ISBN 978-3-319-52444-3. S2CID 23812562. Retrieved 14 January 2021.
  2. ^ Nervewing. "Greater Mind Lesser Body". Erowid Experience Vaults. Erowid. Retrieved 14 January 2021.
  3. ^ "Tihkal 4-HO-DIPT entry".


Categories